Preclin Biosystems


	Models Infectious disease Autoimmune diseases Lung diseases Intestinal diseases Preclin Biosystems’ approach

Preclin Biosystems AG Preclin Biosystems AG offers a comprehensive in vivo preclinical testing platform for the identification and validation of lead candidate therapeutics.
	Our extensive range of chronic inflammatory and infectious disease models are run routinely in our core facility providing a ‘one stop shop’ for preclinical drug efficacy testing. Our parallel testing approach for in vivo assessment of lead candidates can provide an overall efficacy, side effect and target market analysis condensing the preclinical phase of drug development dramatically. For more information on our service and partnership opportunities contact: info@preclinbiosystems.com

News

November 2013: Meet Preclin Biosystems AG at the Bio-Europe 2013 in Vienna (4-6 November). To schedule a meeting contact:
info@preclinbiosystems.com

September 2013: Meet Preclin Biosystems AG at BioPharm America 2013 in Boston (17-19 September). To schedule a meeting contact:
info@preclinbiosystems.com

April 2013: Meet Preclin Biosystems AG at the Bio International Convention 2013 in Chicago (22-25 April). To schedule a meeting contact:
info@preclinbiosystems.com

March 2013: Meet Preclin Biosystems AG at the Bio-Europe Spring 2013 conference in Barcelona (11-13 March). To schedule a meeting contact:
info@preclinbiosystems.com

December 2012: Meet Preclin Biosystems AG at the Outsourcing Preclinical Development conference in Berlin (5 – 6 December). To schedule a meeting contact:
info@preclinbiosystems.com

info@preclinbiosystems.com